Linc AB
STO:LINC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (3), the stock would be worth kr-23.95 (135% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -8.8 | kr69.3 |
0%
|
| 3-Year Average | 3 | kr-23.95 |
-135%
|
| 5-Year Average | 1.8 | kr-14.41 |
-121%
|
| Industry Average | 13.8 | kr-108.48 |
-257%
|
| Country Average | 14.9 | kr-116.7 |
-268%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| SE |
|
Linc AB
STO:LINC
|
4B SEK | -8.8 | -10 | |
| US |
|
BlackRock Inc
NYSE:BLK
|
162B USD | 17.1 | 25.9 | |
| US |
|
Blackstone Inc
NYSE:BX
|
144.5B USD | 21.1 | 49.2 | |
| CA |
|
Brookfield Corp
NYSE:BN
|
102.1B USD | 11.2 | 89.6 | |
| US |
|
Bank of New York Mellon Corp
NYSE:BK
|
92.3B USD | 0 | 17.4 | |
| US |
|
KKR & Co Inc
NYSE:KKR
|
90.8B USD | 282.4 | 40.6 | |
| ZA |
N
|
Ninety One Ltd
JSE:NY1
|
82.3B ZAR | -38.5 | 24.2 | |
| US |
|
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
|
67.3B EUR | 28.2 | 31.2 | |
| CA |
|
Brookfield Asset Management Inc
NYSE:BAM
|
77.9B USD | 28.3 | 31.4 | |
| CA |
B
|
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
|
107.2B CAD | 27.9 | 30.9 | |
| US |
|
Ameriprise Financial Inc
NYSE:AMP
|
42.4B USD | 12.3 | 11.9 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 9.4 |
| Median | 14.9 |
| 70th Percentile | 19.4 |
| Max | 4 325.3 |
Other Multiples
Linc AB
Glance View
Linc AB is an investment company that focuses on long-term share ownership in the Nordic life science market. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2021-05-28. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The firm works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.
